Main news

ADT for Prostate Cancer: What's the Risk on the Heart?
ADT for Prostate Cancer: What's the Risk on the Heart? Androgen deprivation therapy (ADT) for localized prostate cancer increases the risk of myocardial infarction (MI), stroke, and other cardiovascular disease (CVD) events as well as death, according to a study from Norway.


Genetic Test for Six Chronic Diseases Undergoing Clinical Trial
Genetic Test for Six Chronic Diseases Undergoing Clinical Trial A new type of genetic test known as a polygenic risk score could change the way clinicians detect and treat chronic illnesses. But to be widely used, genomic findings in large populations first need to be translated into valid clinical tests for individual patients. Then physicians need meaningful interpretations of test data to help make clinical decisions about patient care.


Greater Triglyceride-Glucose Index Variability Tied to CV Risk
Greater Triglyceride-Glucose Index Variability Tied to CV Risk The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed.


Smokers With Heart Disease Could Gain 5 Years by Quitting
Smokers With Heart Disease Could Gain 5 Years by Quitting Smoking cessation appears to be comparable to the use of three targeted drugs in warding off future major cardiovascular events in smokers with atherosclerotic cardiovascular disease (ASCVD), according to a new study.


FDA Approves Fitbit's AFib-Detection Software
FDA Approves Fitbit's AFib-Detection Software A popular fitness tracker company has received approval from the Food and Drug Administration for a new software algorithm to detect atrial fibrillation (AFib), Fitbit announced on April 11.


The Uphill Struggle for High-Intensity Statins in ASCVD Patients
The Uphill Struggle for High-Intensity Statins in ASCVD Patients New research suggests physicians face a Herculean task to get Americans with atherosclerotic cardiovascular disease (ASCVD) to take high-intensity statins, despite multiple professional guidelines giving the therapy their highest level recommendation.


Pfizer Recalls BP Drugs Because of Potential Carcinogen
Pfizer Recalls BP Drugs Because of Potential Carcinogen Pfizer is voluntarily recalling some antihypertensive medications because of unacceptable levels of a potential carcinogen, the company announced.


Left Atrial Dysfunction Linked to Future Dementia Risk
Left Atrial Dysfunction Linked to Future Dementia Risk A new study has suggested that left atrial dysfunction could be a risk factor for the future development of dementia, raising the possibility of a new approach to dementia prevention.


Calcium Scores Predict Sudden-Death Risk in Preclinical CAD in Large Cohort Study
Calcium Scores Predict Sudden-Death Risk in Preclinical CAD in Large Cohort Study Calcium indicators predict the risk of sudden death in preclinical coronary heart disease in a large cohort study


High Triglycerides Up CV Risk After Atherothrombotic Stroke
High Triglycerides Up CV Risk After Atherothrombotic Stroke Patients who have had a stroke or transient ischemic attack (TIA) of atherothrombotic origin and have high triglyceride levels are at increased risk of having further cardiovascular events, including a recurrent stroke, even if they are taking statins, a new study shows.


World Heart Summit 2022
World Heart Summit 2022 THE SUMMIT WILL CONVENE WORLD LEADERS IN CARDIOVASCULAR HEALTH IN THE HEART OF GLOBAL HEALTH DIPLOMACY, JUST AHEAD OF THE 75TH WORLD HEALTH ASSEMBLY. Now in its 7th edition, the World Heart Summit will take place on 21-22 May 2022, just two days ahead of the World Health Assembly, under the timely and universal theme of Cardiovascular Health for Everyone.


New ACC Guidance on Cardiovascular Consequences of COVID-19
New ACC Guidance on Cardiovascular Consequences of COVID-19 The American College of Cardiology (ACC) has issued an expert consensus clinical guidance document for the evaluation and management of adults with key cardiovascular consequences of COVID-19. The document makes recommendations on how to evaluate and manage COVID-associated myocarditis and long COVID and gives advice on resumption of exercise following COVID-19 infection.


Editorial Activity

cardiology book

Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health.


The Scientific Committee begins accepting abstracts and applications for the scientific program of the XI International Forum of Cardiology and Internal Medicine
The Scientific Committee begins accepting abstracts and applications for the scientific program of the XI International Forum of Cardiology and Internal Medicine Dear Colleagues! We invite you to take part in XI International Forum of Cardiology and Internal Medicine. Forum will take place on 22-24 March 2022 in Moscow (online).


Analysis of the activities of the
Analysis of the activities of the "Cardioprogress" foundation: results of 2021 Dear colleagues! In 2021, a number of significant events took place in cardiology. Due to the continuation of restrictive measures, most scientific events were organized online. This required adaptation and the acquisition of new skills. However, all planned events took place.


Aspirin is linked with increased risk of heart failure
Aspirin is linked with increased risk of heart failure Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition. That’s the finding of a study published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).


Depression worsened during pandemic, boosting heart disease risk, experts warn
Depression worsened during pandemic, boosting heart disease risk, experts warn It may translate into another long-term effect of the coronavirus crisis — more heart disease cases even in people who never had COVID-19 at all. More than one-third of patients studied reported becoming depressed or experiencing continued symptoms of depression during the first year of the pandemic.


Longer Sleep Improves Cardiovascular Outcomes: Time to Make Sleep a Priority
Longer Sleep Improves Cardiovascular Outcomes: Time to Make Sleep a Priority Causal diagrams demonstrating potential relationships between genetic causes (G) of sleep duration, sleep duration (S), and a cardiovascular outcome (Y). (A) G is a valid instrumental variable for the relationship of S and Y, and can be used to estimated the S–Y association (orange arrow). (B) G has a pleiotropic association with Y. Because there are no unmeasured confounders (U) of the S–Y association, causal mediation analysis can be used to estimate both the direct (pleiotropic) association of G and Y, and the indirect effect via S. (C) The pleiotropic effect of G on Y can be measured by blocking the pathway through S, which is done by conditioning on levels of S. (D) The effect of S on Y independently of G can be measured by blocking pathways through G and C (measured confounders) by conditioning or using matching methods.


Medscape and ACC Centers of Excellence
Medscape and ACC Centers of Excellence The ACC has collaborated with Medscape to create two Centers of Excellence on the topics of Cardiovascular Risk Reduction and Heart Failure.


AHA Scientific Sessions 2020 and the Resuscitation Science Symposium 2020!
AHA Scientific Sessions 2020 and the Resuscitation Science Symposium 2020! Welcome to AHA Scientific Sessions 2020 and the Resuscitation Science Symposium (RESS) 2020!